REGISTERED NUMBER: 04939283 (England and Wales)

UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 30 NOVEMBER 2025

FOR

PHARMASEEKERS LIMITED

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Mrs A Banks

Mrs L Midgley

R Midgley

Mrs R West

SECRETARY:

Mrs R West

REGISTERED OFFICE:

6 Nave Close

Darwen

Lancashire

BB3 3JY

REGISTERED NUMBER:

04939283 (England and Wales)

ACCOUNTANTS:

Studholme-Bell Limited

Chartered Certified Accountants

Vantage House

3 East Terrace Business Park

Euxton Lane, Euxton

Chorley

Lancashire

PR7 6TB

FIXED ASSETS

Intangible assets

4

-

-

Tangible assets

5

6,719

5,009

6,719

5,009

CURRENT ASSETS

Debtors

6

62,127

61,229

Investments

7

831

831

Cash at bank

89,276

91,405

152,234

153,465

CREDITORS

Amounts falling due within one year

8

93,811

104,093

NET CURRENT ASSETS

58,423

49,372

TOTAL ASSETS LESS CURRENT LIABILITIES

65,142

54,381

CREDITORS

Amounts falling due after more than one year

9

(18,618

)

(33,844

)

PROVISIONS FOR LIABILITIES

(1,680

)

(1,252

)

NET ASSETS

44,844

19,285

CAPITAL AND RESERVES

Called up share capital

40

40

Retained earnings

44,804

19,245

44,844

19,285

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 10 August 2026 and were signed on its behalf by:

Mrs A Banks - Director

1.	STATUTORY INFORMATION

Pharmaseekers Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill

Goodwill is capitalised and is being amortised over its useful life of 5 years.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc

-

25% on reducing balance

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Research and development

Expenditure on research and development is written off in the year in which it is incurred.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2024 - 5 ) .

4.	INTANGIBLE FIXED ASSETS

Goodwill

£

COST

At 1 December 2024

and 30 November 2025

20,000

AMORTISATION

At 1 December 2024

and 30 November 2025

20,000

NET BOOK VALUE

At 30 November 2025

-

At 30 November 2024

-

5.	TANGIBLE FIXED ASSETS

Fixtures

Plant and

and

Computer

machinery

fittings

equipment

Totals

£

£

£

£

COST

At 1 December 2024

3,892

-

34,383

38,275

Additions

-

207

3,327

3,534

Disposals

-

-

(2,861

)

(2,861

)

At 30 November 2025

3,892

207

34,849

38,948

DEPRECIATION

At 1 December 2024

3,841

-

29,425

33,266

Charge for year

11

29

1,238

1,278

Eliminated on disposal

-

-

(2,315

)

(2,315

)

At 30 November 2025

3,852

29

28,348

32,229

NET BOOK VALUE

At 30 November 2025

40

178

6,501

6,719

At 30 November 2024

51

-

4,958

5,009

6.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

30.11.25

30.11.24

£

£

Trade debtors

61,686

54,511

Other debtors

441

6,718

62,127

61,229

7.	CURRENT ASSET INVESTMENTS

30.11.25

30.11.24

£

£

Listed investments

831

831

8.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

30.11.25

30.11.24

£

£

Trade creditors

6,233

27,031

Taxation and social security

60,304

49,458

Other creditors

27,274

27,604

93,811

104,093

9.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

30.11.25

30.11.24

£

£

Other creditors

18,618

33,844